CD36 and hepatocellular carcinoma: We therefore identified CD36 in these two subclusters, lpmCAFs (c1-mCAF-CD36) and lpCAFs, using specific surface markers and found that they were both enriched in adipogenesis pathways (Fig. 3g) and accounted for ~35% of the CAF population in HCC, indicating their crucial role in HCC progression.